MG53 participates in ischaemic postconditioning through the RISK signalling pathway

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Ischaemic postconditioning (PostC) offers cardioprotection against ischaemia/reperfusion (IR) injury, activating RISK and SAFE pathways.
• MG53 protein was previously identified as a key component of ischaemic preconditioning (IPC).

Purpose of the Study:

• To investigate the role of MG53 in PostC-mediated myocardial protection.
• To elucidate the underlying molecular mechanisms of MG53 in PostC.

Main Methods:

• Langendorff perfusion system used to assess IR injury in wild-type and MG53-deficient mouse hearts.
• Analysis of myocardial damage, necrosis, and apoptosis following IR with or without PostC.
• Investigation of protein-protein interactions involving MG53, caveolin 3 (CaV3), and phosphoinositide 3-kinase (PI3K).

Main Results:

• IR injury was significantly exacerbated in MG53-deficient hearts compared to wild-type.
• PostC failed to protect MG53-deficient hearts, indicating a loss of protective effect.
• Impaired activation of the RISK pathway was observed in MG53-deficient hearts post-PostC.
• MG53 was found to be essential for the interaction between CaV3 and PI3K, mediating RISK pathway activation.

Conclusions:

• MG53 plays a critical role in PostC-mediated cardioprotection.
• MG53 acts by tethering CaV3 and PI3K, leading to the activation of the RISK pathway.
• Targeting MG53 may represent a therapeutic strategy for mitigating IR injury.